REGISTER View Agenda INDUSTRY SUPPORT OPTIONS SUPPORTERS FLYER
This course is designed for neurosurgeons, neurosurgery advanced practice providers (APPs), neurologists, and emergency medicine physicians. It provides information about state-of-the-art diagnosis, workup, and first-line treatments for neurosurgical emergencies. This faced-paced course focuses on emerging technologies that are changing the field. Covered in detail are: advances in stroke management, the emerging role of TXA in intracerebral hemorrhage, the ever-changing landscape of anticoagulation, TBI and spine trauma, and endovascular treatment of chronic SDH. Audience participation will be enhanced through small group discussions occurring in breakout rooms. Learning will be enhanced with recall-centered learning design, as well as case-based learning.
Upon completion of this course, attendees will be able to:
- To describe and discriminate state-of-the-art diagnostic testing for neurosurgical emergencies.
- To implement the correct stroke care for patient with hemorrhage or ischemic stroke.
- To execute correct anticoagulation reversal in the setting of an operative neurosurgical emergency.
- Assemble an effective interprofessional team to treat neurosurgical emergencies.
The Congress of Neurological Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Agenda and faculty subject to change
Thank you to our course supporters!
Click here to learn more about Globus Medical’s technology.
Globus Medical is a Partner of the CNS.
Click here to learn more about Medtronic’s technology.
Medtronic is a Transformational Partner of the CNS.
Click here to learn more about Balt’s technology.
Balt is an Associate Partner of the CNS.
Click here to learn more about Sophysa’s technology.
Sophysa is an Associate Partner of the CNS.
Click here to learn more about Phasor Health’s technology.
Phasor Health is an Associate Partner of the CNS.
This activity is supported by an independent educational grant from AstraZeneca.